PARTICIPANTS Sixty-two subjects with PEX and cataract will be sequentially assigned,
according to a computer-generated randomization list (1:1), to bromfenac (n = 31) or not (n
= 31).

INTERVENTION Cataract surgery by means of phacoemulsification and implantation of
posterior-chamber intraocular lens will be performed by two experienced ophthalmic surgeons.

Standard Arm: only a standard antibiotic and steroid ophthalmic suspension will be given
starting the day after the surgery for two weeks, dosed QID for the first week and BID for
the second week (dexamethasone 0.1% and tobramycin 0.3% eye drops association).

Experimental Arm: eyes will receive bromfenac BID for two weeks starting the day after
surgery. Standard post-operative topical antibiotic and steroid will be also given
concurrently, dosed QID for the first week and BID for the second week (dexamethasone 0.1%
and tobramycin 0.3% eye drops association).

Measurements will be carried out at baseline and after one day, 3 days, 1 week and 4 weeks
from cataract extraction.

Bromfenac eye drops (BID for two weeks starting the day after surgery) plus an antibiotic and steroid eye drop association (QID for the first week and BID for the second week) will be given concurrently to 31 patients.